Cabergoline

Cabergoline

The syndrome nearly always presents either up to eight days once human chorionic gonadotrophin administration in vulnerable patients (early onset) or throughout early physiological state, nine or additional days once human chorionic gonadotrophin administration associated with physiological state ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:NeuroQuantology 2022-01, Vol.20 (8), p.4195
Hauptverfasser: Mohammed Rabie Osman Mahdy, AmgadOsman Gohar, Hashem, Fares Mohammed, Alaa GamalAbd Al Azeem, Mohamed Ahmed Ahmed
Format: Artikel
Sprache:eng
Schlagworte:
Blood vessels
Drug dosages
Females
Ovaries
Physiology
Prevention
Proteins
Vascular endothelial growth factor
Victimization
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The syndrome nearly always presents either up to eight days once human chorionic gonadotrophin administration in vulnerable patients (early onset) or throughout early physiological state, nine or additional days once human chorionic gonadotrophin administration associated with physiological state evoked human chorionic gonadotrophin production.
ISSN:1303-5150
DOI:10.14704/nq.2022.20.8.NQ44453